L-227-2023
Agreement ID
L-227-2023
Lead IC
NICHD
Exclusivity
Exclusive
External Party
EnZeta Immunotherapies, Inc.
Fiscal Year
2023
Territory
Worldwide
Execution Date
Effective Date
Export Date